Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples